Innovation Validation Call 2027

Eligible solutions must be digital or AI-enabled medical devices (MDR/IVDR) at Innovation Maturity Level 6 (IML 6), aiming to reach IML 7 by project end. Please refer to EIT Health’s Healthcare Innovation Cycle Framework for more information on the required Innovation Maturity Level for this call. Funding EIT Health will fund up to 50% of the total project budget, up to €850,000 per project. The commercialising entity must sign a Financial Sustainability Contribution Agreement and, if it is a micro or small enterprise, must receive €400,000–€500,000 of the grant. What we fund Funding supports activities enabling clinical validation (i.e. pivotal clinical studies), regulatory submission (i.e. CE-mark application dossier), product finalisation, market readiness and commercial strategy. Expected outcomes Solutions must have the potential to impact 150,000 patients or citizens in the EU and aim to be on the market and generating at least €10,000 in revenues within three years after the funding period. Key dates Call opens on: 14 October 2026 Call closes on: 13 January 2027 Call information session: 28 October at 12.00 CET – Register here Open Q&A session: 1 December at 15.00 CET – Register here Where to find out more Click here for the official call document and supporting documents How to apply Step 1: Register your organisation in the EU Funding & Tenders Portal to obtain the nine-digit Participant Identification Code (PIC). If you do not know if your organisation already has a PIC number, you can check whether your organisation is already registered on the EU Funding & Tenders Portal . Step 2: Apply to the call via EIT Health’s application platform. Click the ‘Apply’ button below. Apply now About this page